A Phase 3 trial of HIPEC in Ovarian Cancer

Interval cytoreduction with HIPEC (Hyperthermic Intraperitoneal chemotherapy) signficantly improves Recurrence free survival and overall survival when compared to surgery without HIPEC in stage 3 epithelial ovarian cancer

You can find the abstract here

http://abstracts.asco.org/199/AbstView_199_187460.html

Advertisements